ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,285, issued on March 25, was assigned to BioLineRx Ltd. (Modiln, Israel) and Biokine Therapeutics Ltd. (Nes Ziona, Israel).
"Composition of BL-8040" was invented by Efrat Halbfinger (RaAnana, Israel), Amnon Peled (Tel-Aviv, Israel) and Ella Sorani (Kadima, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "A composition comprising BL-8040 (SEQ ID NO: 1) is disclosed herein, which may be for use in treating a condition treatable by BL-8040. The composition further comprises at least one compound characterized by a relative retention time of from 0.86 to 0.88 and/or a relative retention time of from 0.71 to 0.73 (wherein a relative retention time ...